[Click here to subscribe to our NEW weekly newsletter!!]

Lilly Posts 5 Percent Earnings Gain in 2Q
ABC News - Jul 24, 2003
... 2 percent growth in the United States, where Zyprexa faces competition from newer
anti-psychotics, including Bristol-Myers Squibb's Abilify and Pfizer's Geodon ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Austin American Statesman, TX - Jul 24, 2003
... 2 percent growth in the United States, where Zyprexa faces competition from newer
anti-psychotics, including Bristol-Myers Squibb's Abilify and Pfizer's Geodon ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Atlanta Journal Constitution, GA - Jul 24, 2003
... 2 percent growth in the United States, where Zyprexa faces competition from newer
anti-psychotics, including Bristol-Myers Squibb's Abilify and Pfizer's Geodon ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Austin American Statesman, TX - Jul 24, 2003
... 2 percent growth in the United States, where Zyprexa faces competition from newer
anti-psychotics, including Bristol-Myers Squibb's Abilify and Pfizer's Geodon ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Atlanta Journal Constitution, GA - Jul 24, 2003
... 2 percent growth in the United States, where Zyprexa faces competition from newer
anti-psychotics, including Bristol-Myers Squibb's Abilify and Pfizer's Geodon ...

Health sense: Treatment can have unwanted effect
Minneapolis Star Tribune, MN - Jul 20, 2003
... to suicide. Fortunately, several newer drugs, including Geodon and
the recently approved Abilify, don't cause weight gain. Cancer ...

FDA expands use of Zyprexa
Indianapolis Star, IN - Jul 16, 2003
... The approval comes as Zyprexa faces increasing competition from newer antipsychotics,
including Bristol-Myers Squibb's Abilify and Pfizer's Geodon. ...

Healthcast: Autism; Breast Cancer; Zyprexa
INDYchannel.com, IN - Jul 15, 2003
... The approval comes as Zyprexa faces increasing competition from newer anti-psychotics,
including Bristol-Myers Squibb's Abilify and Pfizer's Geodon. ...

FDA gives Lilly's best-selling drug approval for expanded use
Akron Beacon Journal, OH - Jul 15, 2003
... The approval comes as Zyprexa faces increasing competition from newer anti-psychotics,
including Bristol-Myers Squibb's Abilify and Pfizer's Geodon. ...

FDA gives Lilly's best-selling drug approval for expanded use
Kansas City Star, MO - Jul 15, 2003
... The approval comes as Zyprexa faces increasing competition from newer anti-psychotics,
including Bristol-Myers Squibb's Abilify and Pfizer's Geodon. ...

FDA gives Lilly's best-selling drug approval for expanded use
Fort Wayne News Sentinel, IN - Jul 15, 2003
... The approval comes as Zyprexa faces increasing competition from newer anti-psychotics,
including Bristol-Myers Squibb's Abilify and Pfizer's Geodon. ...

FDA gives Lilly's best-selling drug approval for expanded use
Miami Herald, FL - Jul 15, 2003
... The approval comes as Zyprexa faces increasing competition from newer anti-psychotics,
including Bristol-Myers Squibb's Abilify and Pfizer's Geodon. ...

FDA gives Lilly's best-selling drug approval for expanded use
Wichita Eagle, KS - Jul 15, 2003
... The approval comes as Zyprexa faces increasing competition from newer anti-psychotics,
including Bristol-Myers Squibb's Abilify and Pfizer's Geodon. ...

Taking health risks for the sake of looks
Boston Globe, MA - Jul 15, 2003
... that weight gain ''is not just a matter of vanity; it's a serious threat to a person's
general health.'' Fortunately, several newer drugs, including Geodon and ...